CD133 + progenitor cells promote pulmonary hypertension through CXCR4 signaling
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Pulmonary hypertension (PH) is characterized by pulmonary vascular remodeling and smooth muscle cell accumulation, but the progenitor-like cells that contribute to this process remain incompletely defined.
Methods
We combined analyses of human pulmonary arterial hypertension lungs and experimental PH models with bulk and single-cell RNA sequencing, lineage tracing, inducible ablation of CD133 + cells, and conditional deletion of Cxcr4 in CD133 + cells.
Results
CD133 expression was markedly increased in human and experimental PH lungs. Transcriptomic analyses identified inflammatory, metabolic, chemokine-associated, and smooth muscle cell-like programs in CD133 + cells from PH lungs. Lineage tracing showed that CD133 + cells contributed to endothelial and smooth muscle cell compartments during experimental PH. Genetic ablation of CD133 + cells attenuated hypoxia-induced PH and pulmonary vascular remodeling, whereas Cxcr4 deletion in CD133 + cells reduced PH severity.
Conclusions
CD133 + progenitor cells are functional contributors to pulmonary vascular remodeling, and CXCR4 signaling mediates their pathogenic activity. Targeting pathogenic CD133 + cell states or CXCL12/CXCR4 signaling may provide a strategy to limit vascular remodeling in PH.
